Navigation Links
Pelosi Statement on Vote to Approve New Children's Health Insurance Legislation
Date:10/25/2007

WASHINGTON, Oct. 25 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi and House Democratic leaders held a news conference in the Capitol this evening following the vote on the revised bipartisan SCHIP bill, which passed by a vote of 265 to 142. Below are the Speaker's opening remarks:

"Today we took another step forward in providing health insurance for 10 million children. It's an interesting vote. Although we had a number of absences on both sides, we had a situation where on the motion to recommit, the Republicans who all day railed against the increase in taxes in the package, in their motion to recommit, had the same 61-cent tax on cigarettes.

"The only thing is they had fewer children covered by it, approximately 3 million fewer children. They made a point of saying in their presentation that the tax was the same as in the underlying bill. Their motion to recommit last time when the bill first came up was that they had a 45-cent tax. So this whole argument about increasing taxes is bogus, as witnessed by their own motion to recommit. What is disturbing about it though is with the same amount of funding, they insured 3 million fewer children.

"So we have some things to work out between us but I really have no doubt that the conversations that are going on between Democrats and Republicans, House and Senate, will result in a bill going to the President's desk that will ultimately result in the 10 million children being covered.

"I salute my colleagues for the level of debate that they engaged in today, the focus on children. That has been the focus of this Congress. This Congress has been bipartisan and overwhelmingly supportive of children."


'/>"/>
SOURCE Office of the Speaker of the House
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NEW ROBOTIC SURGERY ARM APPROVED BY FDA
2. Abortion Pill approved by FDA
3. Another injectable contraceptive Pill approved by FDA
4. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
5. New FDA Approved Drug To Treat Migraine
6. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. FDA approves Phase 0 trial which tests experimental drugs on humans
9. FDA Approves Contraceptive Ring
10. FDA approves new device to treat womens bleeding disorder
11. FDA Approves New HIV Drug, Viread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... 22, 2017 , ... Ecommerce sales have grown every year since the 1990’s, ... The consequences of rapid innovation and growth are often neglected in the name ... every business and individual’s job to give something back to the planet that provides ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
(Date:4/21/2017)... LAKE CITY, Utah (PRWEB) , ... April 21, ... ... provider of wilderness therapy treatment for adolescents and young adults, has kicked off ... April 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy for ...
(Date:4/21/2017)... ... 2017 , ... The Patient Advocacy Community of The Beryl Institute presented Eve ... Ravich Patient Advocacy Award in recognition of her extraordinary contributions to the field ... at The Beryl Institute’s annual Patient Experience Conference on March 20 in ...
(Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness ... wish to overcome their mental health struggles. The Alive team uses advanced behavioral ... “Our approach in dealing with a mental health struggle is based on 10 ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, ... Segment Forecasts, 2014 - 2025" report to their offering. ... The Latin American ... 21.0 billion by 2025 Low drug registration cost ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
Breaking Medicine Technology: